As seen in Table 1, NAFLD patients were younger, had higher BMI, WC, HbA1c, AST, ALT and adverse lipids and lipid ratios than patients without NAFLD (all P value <0.001). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.